Reagan Jarvis

Co-Founder and CEO at Anocca | Sweden

Reagan Jarvis is the Co-Founder and CEO of Anocca, a T-cell immunotherapy company based out of Sweden, commencing first-in-human clinical trials in 2025 with gene-edited TCR-T cell therapy products in oncology.

A New Zealander, Jarvis obtained his PhD in Biochemistry at University of Otago and performed postdoctoral research at the University of Otago and thereafter the German Cancer Research Center (DKFZ) in Heidelberg. He founded Anocca with Mikael Blomqvist in 2014.

Anocca currently has a pipeline of over 40 products. It has 130+ staff, with 40+ nationalities and operates its own cGMP cell therapy manufacturing site in Södertälje, south of Stockholm